Salubris | Uw Partner Voor Hygiëne

Salubris | Uw Partner Voor Hygiëne company information, Employees & Contact Information

Salubris is sinds 1980 totaalleverancier van schoonmaakproducten en -oplossingen. Als trots deel van de Essaho bedrijvengroep zijn we toegewijd aan innovatie en kwaliteit. Deze groep is de nummer 3 op de Belgische distributie markt in hygiëne- en schoonmaakproducten en schoonmaaksystemen. De klanten zijn een brede waaier aan bedrijven en sectoren, waaronder schoonmaakbedrijven, overheid, zorginstellingen, horeca en industriële ondernemingen. Ons aanbod omvat onder andere hygiënische papierwaren, schoonmaakproducten en -materialen, werkwagens en mopsystemen, poetsmachines, afvalbeheer, disposables, hygiëneartikelen, persoonlijke beschermingsmiddelen en oplossingen voor vaat- en linnenwas. Milieu, ecologie en de mens staan centraal in onze organisatie. Dit vertaalt zich in een uitgebreid duurzaam assortiment en in onze algemene bedrijfsvoering. Bij Salubris streven we er altijd naar om onze klanten de beste oplossingen te bieden.

Company Details

Employees
88
Founded
-
Address
Léon Bekaertlaan 32, Aalter,flemish Region 9880,belgium
Industry
Wholesale
NAICS
Wholesale Trade
Merchant Wholesalers, Durable Goods
Merchant Wholesalers, Nondurable Goods
Office Equipment Merchant Wholesalers
Other Commercial Equipment Merchant Wholesalers
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Ophthalmic Goods Merchant Wholesalers
Other Professional Equipment and Supplies Merchant Wholesalers
Sporting and Recreational Goods and Supplies Merchant Wholesalers
Toy and Hobby Goods and Supplies Merchant Wholesalers
Other Miscellaneous Durable Goods Merchant Wholesalers
Farm Supplies Merchant Wholesalers
Book, Periodical, and Newspaper Merchant Wholesalers
Flower, Nursery Stock, and Florists' Supplies Merchant Wholesalers
Tobacco and Tobacco Product Merchant Wholesalers
Paint, Varnish, and Supplies Merchant Wholesalers
Other Miscellaneous Nondurable Goods Merchant Wholesalers
Professional and Commercial Equipment and Supplies Merchant Wholesalers
HQ
Aalter, Flemish Region
Looking for a particular Salubris | Uw Partner Voor Hygiëne employee's phone or email?

Salubris | Uw Partner Voor Hygiëne Questions

News

Salubris Biotherapeutics Provides Updates on JK07 and JK06 Clinical Programs - Business Wire

Salubris Biotherapeutics Provides Updates on JK07 and JK06 Clinical Programs Business Wire

Interim data success for Salubris Biotherapeutics’ heart failure candidate - Clinical Trials Arena

Interim data success for Salubris Biotherapeutics’ heart failure candidate Clinical Trials Arena

Shenzhen Salubris Pharmaceuticals discovers new tertiary amine compounds - BioWorld MedTech

Shenzhen Salubris Pharmaceuticals discovers new tertiary amine compounds BioWorld MedTech

Salubris Biotherapeutics Announces Positive Interim Data from the Phase 2 Trial of JK07 in Heart Failure - Business Wire

Salubris Biotherapeutics Announces Positive Interim Data from the Phase 2 Trial of JK07 in Heart Failure Business Wire

YolTech sells China rights to cholesterol gene editing therapy to Salubris for $29M - Fierce Biotech

YolTech sells China rights to cholesterol gene editing therapy to Salubris for $29M Fierce Biotech

Salubris Biotherapeutics Appoints Arian Pano, M.D., as Chief Medical Officer - citybiz

Salubris Biotherapeutics Appoints Arian Pano, M.D., as Chief Medical Officer citybiz

Salubris reports positive results from Phase Ib trial of HFrEF therapy - Clinical Trials Arena

Salubris reports positive results from Phase Ib trial of HFrEF therapy Clinical Trials Arena

Salubris Biotherapeutics Announces Dose Escalation Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the European Society for Medical Oncology 2025 Congress - FinancialContent

Salubris Biotherapeutics Announces Dose Escalation Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the European Society for Medical Oncology 2025 Congress FinancialContent

Carlyle Buys Stake in Chinese Health-Care Firm for $260 Million - Bloomberg

Carlyle Buys Stake in Chinese Health-Care Firm for $260 Million Bloomberg

Shenzhen Salubris Pharmaceuticals Gets Acceptance of Clinical Trial Application for Elevated Lipoprotein Drug - MarketScreener

Shenzhen Salubris Pharmaceuticals Gets Acceptance of Clinical Trial Application for Elevated Lipoprotein Drug MarketScreener

Adult day activity center opens in Northeast - El Paso Times

Adult day activity center opens in Northeast El Paso Times

Salubris Plans to Acquire Stake in Swiss Cardiovascular Interventional Therapy Equipment Developer - 一财全球Yicai Global

Salubris Plans to Acquire Stake in Swiss Cardiovascular Interventional Therapy Equipment Developer 一财全球Yicai Global

Yoltech licenses gene editing therapy to Salubris for $145M - BioWorld MedTech

Yoltech licenses gene editing therapy to Salubris for $145M BioWorld MedTech

Shenzhen Salubris Pharmaceuticals Gets Regulatory Acceptance for Clinical Trial Application - MarketScreener

Shenzhen Salubris Pharmaceuticals Gets Regulatory Acceptance for Clinical Trial Application MarketScreener

User - FinancialContent

User FinancialContent

Salubris Biotherapeutics Announces $35 Million in Financing and Provides Pipeline Progress Update - Business Wire

Salubris Biotherapeutics Announces $35 Million in Financing and Provides Pipeline Progress Update Business Wire

Salubris Biotherapeutics Announces European Medicines Agency Approval to Initiate a Phase 1 Clinical Trial of JK06, a 5T4-Targeted ADC, in Solid Tumors - Business Wire

Salubris Biotherapeutics Announces European Medicines Agency Approval to Initiate a Phase 1 Clinical Trial of JK06, a 5T4-Targeted ADC, in Solid Tumors Business Wire

D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China - Business Wire

D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China Business Wire

Shenzhen Salubris Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 54.68 - Markets Mojo

Shenzhen Salubris Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 54.68 Markets Mojo

Shenzhen Salubris Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 52.94 - Markets Mojo

Shenzhen Salubris Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 52.94 Markets Mojo

Salubris Pharma Buys Into Viracta, Eyes Exclusive License for Cancer Treatment - 一财全球Yicai Global

Salubris Pharma Buys Into Viracta, Eyes Exclusive License for Cancer Treatment 一财全球Yicai Global

Shenzhen Salubris Pharma's unit to acquire Salubris Biotherapeutics Inc in U.S. - Reuters

Shenzhen Salubris Pharma's unit to acquire Salubris Biotherapeutics Inc in U.S. Reuters

The U.S. Is Quietly Giving A Chinese Billionaire A Monopoly On A Cancer Drug - HuffPost

The U.S. Is Quietly Giving A Chinese Billionaire A Monopoly On A Cancer Drug HuffPost

The sexy gum: a love story - The Conversation

The sexy gum: a love story The Conversation

WA carbon credits business to hit ASX after $50m float - The West Australian

WA carbon credits business to hit ASX after $50m float The West Australian

Rigg and Grylls carbon credit play inks deal, shelves IPO - The West Australian

Rigg and Grylls carbon credit play inks deal, shelves IPO The West Australian

Residents pitch in to build state-of-the-art hospital - Rappler

Residents pitch in to build state-of-the-art hospital Rappler

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant